[go: up one dir, main page]

WO2002016578A3 - Nouvelles proteines secretees et procedes d'utilisation de ces dernieres - Google Patents

Nouvelles proteines secretees et procedes d'utilisation de ces dernieres Download PDF

Info

Publication number
WO2002016578A3
WO2002016578A3 PCT/US2001/022598 US0122598W WO0216578A3 WO 2002016578 A3 WO2002016578 A3 WO 2002016578A3 US 0122598 W US0122598 W US 0122598W WO 0216578 A3 WO0216578 A3 WO 0216578A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
same
secreted proteins
useful
nucleic acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/022598
Other languages
English (en)
Other versions
WO2002016578A2 (fr
Inventor
Eric Wen Su
He Wang
Yu Zhi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Priority to EP01963725A priority Critical patent/EP1313765A2/fr
Priority to AU2001284651A priority patent/AU2001284651A1/en
Priority to US10/343,953 priority patent/US20030212258A1/en
Publication of WO2002016578A2 publication Critical patent/WO2002016578A2/fr
Publication of WO2002016578A3 publication Critical patent/WO2002016578A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La présente invention concerne des séquences d'acide nucléique codant de nouvelles protéines humaines. Ces nouveaux acides nucléiques sont utiles pour construire les vecteurs d'ADN et les cellules hôtes selon l'invention et pour préparer les acides nucléiques, les protéines de recombinaison et les anticorps selon l'invention qui sont utiles dans les procédés et les utilisations en médecine selon l'invention.
PCT/US2001/022598 2000-08-24 2001-08-17 Nouvelles proteines secretees et procedes d'utilisation de ces dernieres Ceased WO2002016578A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP01963725A EP1313765A2 (fr) 2000-08-24 2001-08-17 Nouvelles proteines secretees et procedes d'utilisation de ces dernieres
AU2001284651A AU2001284651A1 (en) 2000-08-24 2001-08-17 Secreted proteins and methods of using same
US10/343,953 US20030212258A1 (en) 2001-08-17 2001-08-17 Novel secreted proteins and methods of using same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22769700P 2000-08-24 2000-08-24
US60/227,697 2000-08-24

Publications (2)

Publication Number Publication Date
WO2002016578A2 WO2002016578A2 (fr) 2002-02-28
WO2002016578A3 true WO2002016578A3 (fr) 2003-01-16

Family

ID=22854119

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/022598 Ceased WO2002016578A2 (fr) 2000-08-24 2001-08-17 Nouvelles proteines secretees et procedes d'utilisation de ces dernieres

Country Status (3)

Country Link
EP (1) EP1313765A2 (fr)
AU (1) AU2001284651A1 (fr)
WO (1) WO2002016578A2 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8008332B2 (en) 2006-05-31 2011-08-30 Takeda San Diego, Inc. Substituted indazoles as glucokinase activators
US8034822B2 (en) 2006-03-08 2011-10-11 Takeda San Diego, Inc. Glucokinase activators
US8124617B2 (en) 2005-09-01 2012-02-28 Takeda San Diego, Inc. Imidazopyridine compounds
US8163779B2 (en) 2006-12-20 2012-04-24 Takeda San Diego, Inc. Glucokinase activators
US8173645B2 (en) 2007-03-21 2012-05-08 Takeda San Diego, Inc. Glucokinase activators

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997007198A2 (fr) * 1995-08-11 1997-02-27 Genetics Institute, Inc. Sequences d'adn et proteines secretees codees par celles-ci
WO1999056763A1 (fr) * 1998-05-07 1999-11-11 The Regents Of The University Of California Utilisation d'antigenes tissulaires cibles, negliges, pour moduler les reactions immunitaires
WO2001079454A1 (fr) * 2000-04-13 2001-10-25 Smithkline Beecham Corporation Nouveaux composes

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997007198A2 (fr) * 1995-08-11 1997-02-27 Genetics Institute, Inc. Sequences d'adn et proteines secretees codees par celles-ci
WO1999056763A1 (fr) * 1998-05-07 1999-11-11 The Regents Of The University Of California Utilisation d'antigenes tissulaires cibles, negliges, pour moduler les reactions immunitaires
WO2001079454A1 (fr) * 2000-04-13 2001-10-25 Smithkline Beecham Corporation Nouveaux composes

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 7 January 1998 (1998-01-07), LAMERDIN, J.E. ET AL.: "Homo sapiens chromosome 19, cosmid R26624 (LLNLR-226B12), complete sequence.", XP002199809, Database accession no. AC003967 *
KLEIN R D ET AL: "SELECTION FOR GENES ENCODING SECRETED PROTEINS AND RECEPTORS", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 93, no. 14, 9 July 1996 (1996-07-09), pages 7108 - 7113, XP002061411, ISSN: 0027-8424 *
YOKOYAMA-KOBAYASHI M ET AL: "A signal sequence detection system using secreted protease activity as an indicator", GENE, ELSEVIER BIOMEDICAL PRESS. AMSTERDAM, NL, vol. 163, no. 2, 3 October 1995 (1995-10-03), pages 193 - 196, XP004041983, ISSN: 0378-1119 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8124617B2 (en) 2005-09-01 2012-02-28 Takeda San Diego, Inc. Imidazopyridine compounds
US8034822B2 (en) 2006-03-08 2011-10-11 Takeda San Diego, Inc. Glucokinase activators
US8008332B2 (en) 2006-05-31 2011-08-30 Takeda San Diego, Inc. Substituted indazoles as glucokinase activators
US8394843B2 (en) 2006-05-31 2013-03-12 Takeda California, Inc. Substituted isoindoles as glucokinase activators
US8163779B2 (en) 2006-12-20 2012-04-24 Takeda San Diego, Inc. Glucokinase activators
US8173645B2 (en) 2007-03-21 2012-05-08 Takeda San Diego, Inc. Glucokinase activators

Also Published As

Publication number Publication date
AU2001284651A1 (en) 2002-03-04
EP1313765A2 (fr) 2003-05-28
WO2002016578A2 (fr) 2002-02-28

Similar Documents

Publication Publication Date Title
WO2002014358A3 (fr) Nouvelles proteines secretees et leurs utilisations
WO2002008277A3 (fr) Acides nucleiques, vecteurs, cellules hotes, polypeptides et leurs utilisations
WO1999031236A3 (fr) ADNc PROLONGES POUR PROTEINES SECRETEES
WO2001000806A3 (fr) Proteines codant des adn complementaires avec des peptides-signal
WO2002059315A3 (fr) Nouveaux acides nucleiques et polypeptides et procedes de leur utilisation
WO2000006736A3 (fr) Acides nucleiques et proteines de streptococcus groupe b
WO2001032882A3 (fr) Acides nucleiques et proteines provenant des streptocoques du groupe b
WO2002032939A3 (fr) Nouvelles proteines secretees et leurs utilisations
WO2001087978A3 (fr) La 38594, nouveau transporteur humain et ses utilisations
WO2002026801A3 (fr) Nouvelles proteines secretees et utilisations de ces dernieres
WO2002048361A3 (fr) Nouvelles proteines secretees et leurs utilisations
WO2002016578A3 (fr) Nouvelles proteines secretees et procedes d'utilisation de ces dernieres
WO2001092493A3 (fr) Nouvelles aminopeptidases humaines 21956 et 25856, et utilisations
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
WO2002090500A3 (fr) Nouvelles proteines humaines, polynucleotides codant ces proteines et methodes d'utilisation des proteines
WO2002012475A3 (fr) Facteur associe a c1q, polypeptides homologues et utilisations therapeutiques associees
WO2004087886A3 (fr) Constructions adenovirales e1a modifiees et procedes d'utilisation
EP1529843A3 (fr) Protéines sécrétées et leurs utilisations
WO2003029778A3 (fr) Proteines secretees et utilisations associees
WO2002074960A3 (fr) Methodes et compositions relatives aux proteines humaines 38650, 28472, 5495, 65507, 81588 et 14354 et leurs utilisations
WO2004013281A3 (fr) Nouvelles proteines et leurs utilisations
WO2002046408A3 (fr) Nouvelles proteines humaines, polynucleotides les codant et procedes d'utilisation
WO2002048187A3 (fr) Peptides du signal de secretion, leurs sequences adn, vecteurs d'expression pour cellules eucaryotes preparees a partir de ceux-ci, et leur utilisation pour la preparation biotechnologique de proteines
WO2003083048A3 (fr) Nouvelles proteines secretees et leurs utilisations
WO2002002771A3 (fr) Nouveau gene hsparc-11 et procedes de fabrication et d'utilisation de ce dernier

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DK DK DM DZ EC EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 10343953

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2001963725

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001963725

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2001963725

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP